1984
DOI: 10.1097/00007611-198406000-00037
|View full text |Cite
|
Sign up to set email alerts
|

Superior Mesenteric Artery Embolus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1988
1988
2015
2015

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The mortality of acute mesenteric ischemia in adults has been reported at 60-80 % (Debus et al 2011), primarily because of the difficulty of making an early diagnosis before bowel infarction occurs. Surgical intervention (e.g., embolectomy, intestinal resection) (McCready et al 1984) and local intra-arterial infusion of vasodilators (e.g., papaverine) (Boley et al 1981) are used to treat acute mesenteric ischemia, but the mortality of this disease continues to be significant. Experimental nonocclusive mesenteric ischemia in dogs has been treated successfully with intravenously administered vasodilators that are selective for the mesenteric circulation (e.g., urotensin I, sauvagine, and corticotropin-releasing factor) (MacCannell et al 1986), thereby potentially obviating the risk of an indwelling angiographic catheter, but the potential therapeutic effectiveness of these drugs in humans remains unclear.…”
Section: Consequences Of Intestinal Ischemia and Reperfusionmentioning
confidence: 99%
“…The mortality of acute mesenteric ischemia in adults has been reported at 60-80 % (Debus et al 2011), primarily because of the difficulty of making an early diagnosis before bowel infarction occurs. Surgical intervention (e.g., embolectomy, intestinal resection) (McCready et al 1984) and local intra-arterial infusion of vasodilators (e.g., papaverine) (Boley et al 1981) are used to treat acute mesenteric ischemia, but the mortality of this disease continues to be significant. Experimental nonocclusive mesenteric ischemia in dogs has been treated successfully with intravenously administered vasodilators that are selective for the mesenteric circulation (e.g., urotensin I, sauvagine, and corticotropin-releasing factor) (MacCannell et al 1986), thereby potentially obviating the risk of an indwelling angiographic catheter, but the potential therapeutic effectiveness of these drugs in humans remains unclear.…”
Section: Consequences Of Intestinal Ischemia and Reperfusionmentioning
confidence: 99%